Table: Taisho Pharmaceutical HD -2023/24 div forecast
Nov 24 (Reuters) -
Taisho Pharmaceutical Holdings Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full year to Full year to
Mar 31, 2024 Mar 31, 2024
LATEST PREVIOUS
FORECAST FORECAST
Annual Div 50.00 yen 100.00 yen
-Q4 Div NIL 50.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in 2006
allowed companies to pay and report dividends on a quarterly basis.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10